Literature DB >> 21410023

Identification of obstructive jaundice-related microRNAs in mouse liver.

Tomohiro Kanda1, Osamu Ishibashi, Yutaka Kawahigashi, Takuya Mishima, Takuji Kosuge, Yoshiaki Mizuguchi, Tetsuya Shimizu, Yasuo Arima, Shigeki Yokomuro, Hiroshi Yoshida, Takashi Tajiri, Eiji Uchida, Toshihiro Takizawa.   

Abstract

BACKGROUND/AIMS: Although microRNAs are known to be post-transcriptional regulators in physiological and pathological events in the liver, their role in the obstructive jaundice liver remains unclear.
METHODOLOGY: We sequenced the small RNA libraries of the bile duct ligation (BDL) mouse liver to detect the in vivo microRNA expression profiles of obstructive jaundice. We also validated the differential expression of microRNAs in the BDL liver using real-time PCR. Laser microdissection was performed to identify the origin of BDL-related microRNAs. An IL6-treated normal intrahepatic biliary epithelial cell line was used as an in vitro model of obstructive jaundice.
RESULTS: We found microRNAs that were upregulated in the BDL liver (let-7a, let-7d, let-7f, let-7g, miR-21, miR-125a-5p, miR-125b-5p, miR-194, miR-199a-3p, miR-199a-5p, miR-214, miR-221, and miR-486). Furthermore, laser-microdissection analysis showed that miR-199a-5p was significantly upregulated in the intrahepatic bile duct of the BDL liver. The in vitro expression of miR-199a-5p was appreciably elevated in accordance with increased proliferation of IL6-treated cells.
CONCLUSIONS: We revealed dynamic changes in microRNA expression during obstructive jaundice using the BDL model. MiR-199a-5p was likely associated with the proliferation of intrahepatic bile ducts. Our data will facilitate further study of the pathophysiological role(s) of microRNAs in the obstructive jaundice liver.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21410023

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.

Authors:  Tarek M K Motawi; Nermin A H Sadik; Olfat G Shaker; Maggy H Ghaleb
Journal:  Tumour Biol       Date:  2016-01-26

2.  Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.

Authors:  Qingqing Zhang; Mingyi Xu; Ying Qu; Zhenghong Li; Qidi Zhang; Xiaobo Cai; Lungen Lu
Journal:  Mol Med Rep       Date:  2015-08-12       Impact factor: 2.952

3.  microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C.

Authors:  Kendall R Van Keuren-Jensen; Ivana Malenica; Amanda L Courtright; Layla T Ghaffari; Alex P Starr; Raghu P Metpally; Taylor A Beecroft; Elizabeth W J Carlson; Jeffrey A Kiefer; Paul J Pockros; Jorge Rakela
Journal:  Liver Int       Date:  2015-09-09       Impact factor: 5.828

4.  p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.

Authors:  Ruhao Yang; Xuan Xu; Huiling Li; Jinwen Chen; Xudong Xiang; Zheng Dong; Dongshan Zhang
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

Review 5.  Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a.

Authors:  Shen Gu; Wai-Yee Chan
Journal:  Int J Mol Sci       Date:  2012-07-09       Impact factor: 6.208

6.  microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress.

Authors:  B-H Dai; L Geng; Y Wang; C-J Sui; F Xie; R-X Shen; W-F Shen; J-M Yang
Journal:  Cell Death Dis       Date:  2013-04-18       Impact factor: 8.469

7.  miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.

Authors:  Christian Lacks Lino Cardenas; Imène Sarah Henaoui; Elisabeth Courcot; Christoph Roderburg; Christelle Cauffiez; Sébastien Aubert; Marie-Christine Copin; Benoit Wallaert; François Glowacki; Edmone Dewaeles; Jadranka Milosevic; Julien Maurizio; John Tedrow; Brice Marcet; Jean-Marc Lo-Guidice; Naftali Kaminski; Pascal Barbry; Tom Luedde; Michael Perrais; Bernard Mari; Nicolas Pottier
Journal:  PLoS Genet       Date:  2013-02-14       Impact factor: 5.917

Review 8.  MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  J Clin Med       Date:  2015-05-20       Impact factor: 4.964

9.  Circulating liver-specific miR-122 as a novel potential biomarker for diagnosis of cholestatic liver injury.

Authors:  Huang Shifeng; Wang Danni; Chen Pu; Yang Ping; Cao Ju; Zhang Liping
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.